XML 16 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Follow-On Offering
At-The-Market Offering
Common Stock
Common Stock
Follow-On Offering
Common Stock
At-The-Market Offering
Additional Paid-In Capital
Additional Paid-In Capital
Follow-On Offering
Additional Paid-In Capital
At-The-Market Offering
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Beginning balance (in shares) at Dec. 31, 2024       19,422,358              
Beginning balance at Dec. 31, 2024 $ 445,450     $ 14     $ 1,281,522     $ (836,740) $ 654
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation expense 8,786           8,786        
Issuance of common stock (in shares)           694,212          
Issuance of common stock     $ 54,904           $ 54,904    
Issuance of common stock from exercise of pre-funded warrants (in shares)       173,840              
Vesting of restricted stock awards (in shares)       55,850              
Shares withheld for taxes for vesting of restricted stock units (in shares)       (18,765)              
Shares withheld for taxes for vesting of restricted stock units (1,195)           (1,195)        
Issuance of common stock upon exercise of stock options (in shares)       14,422              
Issuance of common stock upon exercise of stock options 560           560        
Change in unrealized gain on marketable securities, net of tax 5                   5
Net loss (69,296)                 (69,296)  
Ending balance (in shares) at Mar. 31, 2025       20,341,917              
Ending balance at Mar. 31, 2025 439,214     $ 14     1,344,577     (906,036) 659
Beginning balance (in shares) at Dec. 31, 2024       19,422,358              
Beginning balance at Dec. 31, 2024 $ 445,450     $ 14     1,281,522     (836,740) 654
Ending balance (in shares) at Dec. 31, 2025 25,195,092     25,195,092              
Ending balance at Dec. 31, 2025 $ 878,136     $ 15     2,017,566     (1,140,008) 563
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation expense 17,112           17,112        
Issuance of common stock (in shares)         2,543,800            
Issuance of common stock   $ 621,235           $ 621,235      
Vesting of restricted stock awards (in shares)       134,225              
Shares withheld for taxes for vesting of restricted stock units (in shares)       (45,548)              
Shares withheld for taxes for vesting of restricted stock units $ (12,923)           (12,923)        
Issuance of common stock upon exercise of stock options (in shares) 25,402     31,945              
Issuance of common stock upon exercise of stock options $ 1,119           1,119        
Change in unrealized gain on marketable securities, net of tax (2,157)                   (2,157)
Net loss $ (92,561)                 (92,561)  
Ending balance (in shares) at Mar. 31, 2026 27,859,514     27,859,514              
Ending balance at Mar. 31, 2026 $ 1,409,961     $ 15     $ 2,644,109     $ (1,232,569) $ (1,594)